Hancock Whitney’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.77M | Sell |
34,345
-741
| -2% | -$61.1K | 0.05% | 270 |
|
|
2025
Q4 | $2.99M | Buy |
35,086
+433
| +1% | +$35.5K | 0.05% | 237 |
|
|
2025
Q3 | $2.69M | Sell |
34,653
-716
| -2% | -$55.9K | 0.05% | 253 |
|
|
2025
Q2 | $2.77M | Buy |
35,369
+26,919
| +319% | +$2.01M | 0.05% | 241 |
|
|
2025
Q1 | $612K | Sell |
8,450
-11,929
| -59% | -$854K | 0.02% | 404 |
|
|
2024
Q4 | $1.51M | Sell |
20,379
-10,362
| -34% | -$725K | 0.05% | 250 |
|
|
2024
Q3 | $2.03M | Sell |
30,741
-92
| -0.3% | -$6.68K | 0.07% | 200 |
|
|
2024
Q2 | $2.85M | Sell |
30,833
-335
| -1% | -$29.7K | 0.1% | 148 |
|
|
2024
Q1 | $2.98M | Sell |
31,168
-2,109
| -6% | -$177K | 0.1% | 148 |
|
|
2023
Q4 | $2.54M | Sell |
33,277
-1,256
| -4% | -$87.4K | 0.09% | 172 |
|
|
2023
Q3 | $2.39M | Sell |
34,533
-3,255
| -9% | -$262K | 0.1% | 163 |
|
|
2023
Q2 | $3.56M | Sell |
37,788
-5,578
| -13% | -$485K | 0.14% | 125 |
|
|
2023
Q1 | $3.59M | Sell |
43,366
-10,907
| -20% | -$857K | 0.14% | 128 |
|
|
2022
Q4 | $4.05M | Sell |
54,273
-140,504
| -72% | -$10.8M | 0.16% | 119 |
|
|
2022
Q3 | $16.1M | Sell |
194,777
-5,893
| -3% | -$567K | 0.69% | 33 |
|
|
2022
Q2 | $19.1M | Sell |
200,670
-4,397
| -2% | -$455K | 0.76% | 32 |
|
|
2022
Q1 | $24.1M | Sell |
205,067
-865
| -0.4% | -$97K | 0.82% | 30 |
|
|
2021
Q4 | $26.7M | Buy |
205,932
+1,188
| +0.6% | +$139K | 0.84% | 24 |
|
|
2021
Q3 | $23.2M | Sell |
204,744
-7,562
| -4% | -$863K | 0.81% | 25 |
|
|
2021
Q2 | $22M | Sell |
212,306
-2,261
| -1% | -$213K | 0.7% | 25 |
|
|
2021
Q1 | $17.9M | Sell |
214,567
-4,547
| -2% | -$384K | 0.61% | 33 |
|
|
2020
Q4 | $20M | Sell |
219,114
-2,582
| -1% | -$214K | 0.67% | 31 |
|
|
2020
Q3 | $17.7M | Sell |
221,696
-3,136
| -1% | -$245K | 0.65% | 33 |
|
|
2020
Q2 | $15.5M | Sell |
224,832
-12,255
| -5% | -$871K | 0.6% | 37 |
|
|
2020
Q1 | $14.9M | Buy |
237,087
+828
| +0.4% | +$59.7K | 0.58% | 33 |
|
|
2019
Q4 | $18.4M | Buy |
236,259
+36,936
| +19% | +$2.88M | 0.59% | 27 |
|
|
2019
Q3 | $14.6M | Sell |
199,323
-5,031
| -2% | -$353K | 0.48% | 43 |
|
|
2019
Q2 | $12.6M | Sell |
204,354
-12,423
| -6% | -$751K | 0.4% | 61 |
|
|
2019
Q1 | $13.8M | Sell |
216,777
-6,234
| -3% | -$356K | 0.44% | 46 |
|
|
2018
Q4 | $11.4M | Sell |
223,011
-38,820
| -15% | -$1.96M | 0.38% | 62 |
|
|
2018
Q3 | $15.2M | Buy |
+261,831
| New | +$12.8M | 0.43% | 50 |
|
|
2017
Q1 | – | Sell |
-412,581
| Closed | -$12.9M | – | 567 |
|
|
2016
Q4 | $12.9M | Buy |
412,581
+2,001
| +0.5% | +$64.8K | 0.48% | 84 |
|
|
2016
Q3 | $16.5M | Sell |
410,580
-46,329
| -10% | -$1.74M | 0.65% | 15 |
|
|
2016
Q2 | $15.2M | Sell |
456,909
-67,305
| -13% | -$2.3M | 0.63% | 26 |
|
|
2016
Q1 | $15.4K | Sell |
524,214
-26,742
| -5% | -$738K | 0.65% | 25 |
|
|
2015
Q4 | $14.5M | Buy |
+550,956
| New | +$14.3M | 0.61% | 45 |
|
Other funds holding EW
VCM
VPM
Hancock Whitney's EW Position: Q1 2026 in Review
Hancock Whitney reduced its Edwards Lifesciences (EW) stake by 2.1% in Q1 2026, selling an estimated $61.1K and leaving 34,345 shares worth $2.77M. The position accounts for 0.05% of the portfolio, ranked #270.
Hancock Whitney first reported a position in EW in Q4 2015 and has held it in 36 quarters since. The position peaked at $26.7M in Q4 2021. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.
- Hancock Whitney held 34,345 shares of Edwards Lifesciences worth $2.77M as of Q1 2026.
- Hancock Whitney sold 741 Edwards Lifesciences shares in Q1 2026, an estimated $61.1K.
- Edwards Lifesciences made up 0.05% of Hancock Whitney's portfolio in Q1 2026, its #270 holding.
- Hancock Whitney first reported a position in Edwards Lifesciences in Q4 2015 and has held it in 36 quarters since.
- Hancock Whitney's Edwards Lifesciences position peaked at $26.7M in Q4 2021.
- 1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.
Based on Hancock Whitney's 13F filing for Q1 2026, filed 15 May 2026.